Kisspeptin-10, also known as KP-10 or metastin (45–54), is a synthetic decapeptide corresponding to the final ten amino acids of the naturally occurring human kisspeptin protein. It belongs to the kisspeptin family of neuropeptides and is investigated for its involvement in reproductive endocrinology and neuroendocrine signalling.
Kisspeptins are produced from a precursor protein encoded by the KISS1 gene. Their biological activity is mediated primarily through the kisspeptin receptor, also known as KISS1R or GPR54, a G-protein-coupled receptor expressed in several tissues, including areas of the hypothalamus involved in reproductive hormone regulation.
Kisspeptin signalling is an important component of the communication between the brain and the reproductive endocrine system. Research has established that this signalling pathway can influence gonadotropin-releasing hormone (GnRH) secretion, which in turn regulates the release of luteinising hormone (LH) and follicle-stimulating hormone (FSH) from the anterior pituitary gland.
KP-10 is particularly relevant to laboratory investigations because it represents the shortest naturally occurring kisspeptin sequence known to retain substantial activity at KISS1R.
Chemical Identity and Properties
- Name: Kisspeptin-10
- Abbreviation: KP-10 / KP10
- Alternative name: Metastin (45–54)
- CAS number: 374675-21-5
- Molecular formula: C₆₃H₈₃N₁₇O₁₄
- Molecular weight: approximately 1,302.4 g/mol
- Peptide length: 10 amino acids
- Amino-acid sequence: H-Tyr-Asn-Trp-Asn-Ser-Phe-Gly-Leu-Arg-Phe-NH₂
- Primary receptor: KISS1R / GPR54
The C-terminal amidated phenylalanine is an important structural feature of kisspeptin peptides. The conserved C-terminal region is closely associated with receptor recognition and biological activity.
The molecular formula and molecular weight refer to the free peptide structure. A salt form, such as an acetate preparation, may have a different total molecular weight depending on its composition and counterion content. Product identity and salt form should therefore be confirmed through the relevant analytical documentation.
Biological Background: The Kisspeptin System
Kisspeptin was initially investigated in connection with the KISS1 gene, which was identified in cancer-metastasis research. Subsequent work established a major role for kisspeptin signalling in reproductive physiology.
The KISS1 gene encodes a precursor protein that can be processed into several biologically active kisspeptin fragments, including KP-54, KP-14, KP-13 and KP-10. These peptides share a conserved C-terminal sequence that is important for interaction with KISS1R.
The discovery that mutations affecting KISS1R signalling can disrupt normal pubertal development provided important evidence that the kisspeptin pathway is essential to reproductive maturation.
Today, kisspeptin signalling is studied in relation to:
- Hypothalamic regulation of reproductive hormones.
- GnRH neuronal activity.
- LH and FSH secretion.
- Pubertal development.
- Reproductive endocrine feedback mechanisms.
- Ovarian and testicular endocrine physiology.
- The interaction between metabolic status and reproductive function.
KP-10 is used in experimental research to investigate these processes at the receptor and neuroendocrine levels.
Mechanism of Action
Kisspeptin-10 acts primarily as an agonist of the kisspeptin receptor, KISS1R, also known as GPR54.
KISS1R is a G-protein-coupled receptor. When activated by kisspeptin, it initiates intracellular signalling pathways that can influence neuronal activity and hormone secretion.
The best-established physiological pathway involves the hypothalamic regulation of GnRH neurons.
1. KISS1R Activation
KP-10 binds to KISS1R and activates receptor-associated intracellular signalling. This involves G-protein-mediated pathways, including phospholipase C signalling and downstream changes in intracellular calcium and protein kinase activity.
These signalling events contribute to the activation of neuronal pathways associated with reproductive endocrine regulation.
2. GnRH Signalling
Kisspeptin-sensitive neural circuits provide a major stimulatory input to GnRH neurons. GnRH is released into the hypophyseal portal circulation and acts on the anterior pituitary gland.
The resulting pituitary response includes the secretion of LH and FSH.
3. LH and FSH Regulation
LH and FSH are gonadotropins involved in reproductive physiology.
In males, LH stimulates testosterone production by Leydig cells, while FSH contributes to Sertoli-cell function and spermatogenesis.
In females, LH and FSH participate in follicular development, ovulation, corpus luteum function and ovarian steroid production.
The relationship between kisspeptin, GnRH and gonadotropins is therefore an important subject in reproductive endocrinology.
It is important to distinguish this established biological pathway from claims about predictable clinical outcomes. The effects of an experimental peptide depend on the study model, administration conditions, biological state and other variables.
Research Applications
Reproductive Endocrinology
Kisspeptin-10 is investigated as a molecular tool for studying the regulation of the hypothalamic-pituitary-gonadal axis.
Researchers use kisspeptin signalling to examine how the central nervous system communicates with the reproductive endocrine system and how hormonal feedback influences reproductive function.
GnRH Neuronal Activity
The relationship between kisspeptin and GnRH neurons is one of the most important areas of kisspeptin research.
Experimental studies investigate how KISS1R activation influences GnRH neuronal activity and the release of reproductive hormones. This research contributes to a broader understanding of the neural mechanisms controlling reproductive physiology.
Pubertal Development
Kisspeptin signalling is associated with the activation of reproductive endocrine function during puberty.
Research into the KISS1/KISS1R pathway has helped clarify the mechanisms involved in the transition from childhood to reproductive maturity. Genetic disruptions affecting this pathway can be associated with abnormal pubertal development.
Fertility Research
Kisspeptin peptides have been investigated in experimental and clinical research involving reproductive hormone regulation and fertility-related physiology.
However, results obtained with one kisspeptin form, administration route or clinical preparation cannot automatically be applied to KP-10 research material. Studies involving KP-54, for example, should not be presented as direct evidence for the safety or effectiveness of a KP-10 product.
Metabolic and Neuroendocrine Research
The kisspeptin system is also studied in relation to metabolic signalling. Reproductive function is influenced by nutritional status, energy availability and metabolic hormones.
Researchers investigate how these signals interact with kisspeptin pathways and whether metabolic conditions can influence reproductive neuroendocrine activity.
Pharmacological Considerations
KP-10 is a peptide ligand rather than a conventional small-molecule drug. Its biological activity depends on its interaction with KISS1R and the physiological context in which the receptor is expressed.
Peptides are generally susceptible to enzymatic degradation. Their stability can be influenced by temperature, pH, solvent conditions, proteolytic enzymes and formulation characteristics.
Experimental observations should not be interpreted as a universal prediction of activity in humans. Differences in species, experimental models, peptide preparation, purity and administration conditions can produce substantially different results.
Repeated or sustained stimulation of a receptor system may also produce different responses from a single experimental exposure. The possibility of altered responsiveness during prolonged stimulation is relevant when interpreting preclinical findings.
Dosage and Administration Information
Kisspeptin-10 is not an approved medicine with an established, universally accepted human dosage regimen.
Research protocols may differ in peptide form, concentration, route, frequency and study duration. Doses reported in individual publications are specific to the experimental design and should not be converted into instructions for self-administration.
The existence of human research involving kisspeptin does not establish the safety of unapproved research-grade products. It also does not establish a suitable dose, frequency or treatment duration for a commercial peptide preparation.
For this reason, no human-use dosage or injection protocol is provided for this research product.
Safety Profile and Potential Risks
The available safety evidence for KP-10 is limited compared with that for approved medicines. Short-duration research involving controlled preparations does not establish the safety of repeated or long-term use.
In its review of kisspeptin-10 for potential compounding use, the US Food and Drug Administration identified significant gaps in the available safety information. These included uncertainty about appropriate dosing, frequency and duration, as well as potential immunogenicity associated with certain administration routes.
Important considerations include:
- Immunogenicity: Peptide products can potentially trigger immune responses. The risk may depend on peptide structure, impurities, aggregation, manufacturing quality and route of administration.
- Endocrine effects: Because KP-10 can influence reproductive hormone signalling, unintended changes in LH, FSH or downstream reproductive hormones are biologically plausible.
- Uncertain long-term safety: There is insufficient evidence to establish the safety of chronic or repeated administration.
- Product quality: Incorrect sequence, degradation, contamination, residual solvents, counterion content and inaccurate concentration can affect product identity and quality.
- Experimental variability: Results from one preparation or study cannot be assumed to apply to another product.
The absence of a reported serious adverse event in a small or short-duration study should not be interpreted as proof of safety.
Regulatory Status
Kisspeptin-10 is not an FDA-approved drug product. The FDA’s 2024 Pharmacy Compounding Advisory Committee review identified insufficient evidence to establish its safety and effectiveness for the proposed medical uses and raised concerns about the quality and characterisation of the substance.
The FDA review also noted that no approved product containing kisspeptin-10 was available at the time of its assessment.
Regulatory status can differ between jurisdictions and may change. Research-grade material should not be represented as an approved fertility treatment, hormone therapy or substitute for prescribed medication.
Storage and Handling
Peptide stability depends on the formulation, manufacturing process and storage conditions specified by the supplier.
For laboratory materials, follow the product-specific certificate of analysis and handling documentation. Avoid repeated temperature cycling, unnecessary exposure to moisture and prolonged exposure to conditions that may accelerate peptide degradation.
A visual inspection alone cannot establish peptide identity, purity, concentration or biological activity. Appropriate analytical methods, including chromatographic and mass-spectrometric testing, are required for meaningful quality assessment.
Summary
Kisspeptin-10 (KP-10) is a synthetic decapeptide derived from the C-terminal region of human kisspeptin. Its primary research significance lies in its activity at the KISS1R/GPR54 receptor and its role in the regulation of GnRH neuronal signalling.
By influencing the hypothalamic-pituitary-gonadal axis, kisspeptin signalling provides an important model for investigating reproductive endocrinology, pubertal development and hormonal feedback mechanisms.
Despite substantial scientific interest, KP-10 remains an investigational peptide rather than an approved medicine. Important questions remain regarding long-term safety, appropriate administration parameters, immunogenicity and the quality requirements for peptide preparations.
Research-use notice: This product is intended strictly for laboratory research and analytical purposes. It is not intended for human or veterinary consumption, diagnosis, treatment or prevention of disease.





Reviews
There are no reviews yet.